Analgesic Allergy Labels Linked to Adverse Birth Outcomes
A new study shows that a non-narcotic analgesics allergy label (NNAAL) in expectant mothers is associated with adverse outcomes. These include increased rates of NICU admission, preterm birth, and eclampsia for both the mother and infant.
- The study was a large-scale retrospective analysis that examined electronic health records from over 2.2 million singleton live births in California between 2016 and 2021. This type of research, using massive datasets, is a hallmark of computational biology and bioinformatics, where scientists write code to find patterns in patient data. - The lead author of the study, Dr. Chang Su, noted that mothers with a non-narcotic analgesics allergy label (NNAAL) had a 1.5 times increased risk for eclampsia, a 1.21 times increased risk for preterm birth, and a 1.17 times increased risk for their infant's admission to the NICU. - A key takeaway from the research is the potential benefit of "de-labeling," as many people with an allergy label may not be truly allergic. For instance, studies on penicillin allergies show that over 90% of patients with a penicillin allergy label can actually tolerate the antibiotic after proper evaluation by a specialist. - The presence of an allergy label often leads to the use of alternative medications which may be less effective or carry their own risks; for example, mothers with an NSAID allergy label have been found to have higher rates of opioid use for pain management after giving birth. - In a study like this, a clinical researcher's role would be patient-facing and focused on the integrity of the initial data. They manage clinical trials, recruit and screen participants, obtain informed consent, and ensure the data collected in patient records is accurate and adheres to strict protocols, which is the foundational work for any later analysis. - A computational biologist or bioinformatician would then take the massive, anonymized dataset collected from electronic health records. Their work involves writing computer programs (often in languages like Python or R) to clean the data, develop algorithms, and apply statistical models to identify the very associations highlighted in the headline. - The educational path for these roles differs significantly: patient-facing clinical research often requires a medical degree (MD) or a Master of Public Health (MPH), focusing on biology, ethics, and patient care. A computational biologist typically pursues a Ph.D. in a field combining computer science, statistics, and biology, with a heavy emphasis on programming and data analysis. - This study is a prime example of how these two fields collaborate to advance medicine. Clinical researchers work in hospitals and clinics to generate high-quality patient data, while computational biologists use that data to answer large-scale questions that would be impossible to address on a case-by-case basis.
